Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus

Journal of Virology

Volumn 77, Issue 12, 2003, Pages 7131-7138

  Pariente, Nonia ^a   Airaksinen, Antero ^a   Domingo, Esteban ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; COMPLEMENTARY DNA; CYTIDINE TRIPHOSPHATE; FLUOROURACIL; FLUOROURACIL TRIPHOSPHATE; GUANIDINE; GUANOSINE TRIPHOSPHATE; HEPARIN; MUTAGENIC AGENT; NUCLEOTIDE DERIVATIVE; PROTEIN 2C; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN BHK; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR SPACE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; INTRACELLULAR SPACE; MOLECULAR CLONING; MUTAGENESIS; MUTATION RATE; NONHUMAN; PHENOTYPE; PICORNAVIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES EXTINCTION; VIRAL EXTINCTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS MUTANT; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CRICETINAE; DRUG COMBINATIONS; FLUOROURACIL; FOOT-AND-MOUTH DISEASE VIRUS; GUANIDINE; HEPARIN; MUTAGENS; MUTATION;

EID: 0038278911     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.12.7131-7138.2003     Document Type: Article

References (60)

1. Airaksinen, A., N. Pariente, L. Menéndez-Arias, and E. Domingo. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology, in press.
2. Anderson-Sillman, K., S. Bartal, and D. R. Tershak. 1984. Guanidine-resistant poliovirus mutants produce modified 37-kilodalton proteins. J. Virol. 50:922-928.
3. Baltera, R. F., Jr., and D. R. Tershak. 1989. Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C. J. Virol. 63:4441-4444.
4. Baranowski, E., C. M. Ruiz-Jarabo, N. Sevilla, D. Andreu, E. Beck, and E. Domingo. 2000. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J. Virol. 74:1641-1647.
5. Baranowski, E., N. Sevilla, N. Verdaguer, C. M. Ruiz-Jarabo, E. Beck, and E. Domingo. 1998. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J. Virol. 72:6362-6372.
6. Caplen, H., C. J. Peters, and D. H. Bishop. 1985. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J. Gen. Virol. 66:2271-2277.
7. Charpentier, N., M. Davila, E. Domingo, and C. Escarmis. 1996. Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene. Virology 223:10-18.
8. Chu, W. C., V. Feiz, W. B. Derrick, and J. Horowitz. 1992. Fluorine-19 nuclear magnetic resonance as a probe of the solution structure of mutants of 5-fluorouracil-substituted Escherichia coli valine tRNA. J. Mol. Biol. 227: 1164-1172.
9. Crotty, S., C. E. Cameron, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 98: 6895-6900.
10. Crotty, S., D. Maag, J. J. Arnold, W. Zhong, J. Y. Lau, Z. Hong, R. Andino, and C. E. Cameron. 2000. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6:1375-1379.
11. Domingo, E., C. K. Biebricher, J. J. Holland, and M. Eigen. 2001. Quasispecies and RNA virus evolution: principles and consequences. Landes Bioscience, Austin, Tex.
12. Domingo, E., M. Davila, and J. Ortin. 1980. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene 11:333-346.
13. Eastman, P. S., and C. D. Blair. 1985. Temperature-sensitive mutants of Japanese encephalitis virus. J. Virol. 55:611-616.
14. Eigen, M. 2002. Error catastrophe and antiviral strategy. Proc. Natl. Acad. Sci. USA 99:13374-13376.
15. Eigen, M., and C. K. Briebricher. 1988. Sequence space and quasispecies distribution, p. 211-245. In P. A. E. Domingo and J. J. Holland (ed.), RNA genetics, vol. 3. CRC Press, Boca Raton, Fla.
16. Escarmís, C., M. Davila, N. Charpentier, A. Bracho, A. Moya, and E. Domingo. 1996. Genetic lesions associated with Muller's ratchet in an RNA virus. J. Mol. Biol. 264:255-267.
17. Escarmís, C., M. Davila, and E. Domingo. 1999. Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. J. Mol. Biol. 285:495-505.
18. Escarmís, C., G. Gomez-Mariano, M. Davila, E. Lazaro, and E. Domingo. 2002. Resistance to extinction of low fitness virus subjected to plaque-to-plaque transfers: diversification by mutation clustering. J. Mol. Biol. 315: 647-661.
19. Ghosh, A., R. Nayak, and M. S. Shaila. 1996. Inhibition of replication of rinderpest virus by 5-fluorouracil. Antiviral Res. 31:35-44.
20. Ghoshal, K., and S. T. Jacob. 1997. An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug. Biochem. Pharmacol. 53:1569-1575.
21. Grande-Pérez, A., S. Sierra, M. G. Castro, E. Domingo, and P. R. Lowenstein. 2002. From the cover: molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc. Natl. Acad. Sci. USA 99:12938-12943.
22. Haspel, M. V., P. W. Lampert, and M. B. Oldstone. 1978. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc. Natl. Acad. Sci. USA 75:4033-4036.
23. Holland, J. J., E. Domingo, J. C. de la Torre, and D. A. Steinhauer. 1990. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64:3960-3962.
24. Jackson, T., F. M. Ellard, R. A. Ghazaleh, S. M. Brookes, W. E. Blakemore, A. H. Corteyn, D. I. Stuart, J. W. Newman, and A. M. King. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282-5287.
25. Klein, M., D. Hadaschik, H. Zimmermann, H. J. Eggers, and B. Nelsen-Salz. 2000. The picornavirus replication inhibitors HBB and guanidine in the echovirus-9 system: the significance of viral protein 2C. J. Gen. Virol. 81: 895-901.
26. Kunz, B. A., and S. E. Kohalmi. 1991. Modulation of mutagenesis by deoxyribonucleotide levels. Annu. Rev. Genet. 25:339-359.
27. Lanford, R. E., D. Chavez, B. Guerra, J. Y. Lau, Z. Hong, K. M. Brasky, and B. Beames. 2001. Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. J. Virol. 75:8074-8081.
28. Lenz, H. J., D. J. Manno, K. D. Danenberg, and P. V. Danenberg. 1994. Incorporation of 5-fluorouracil into U2 and U6 snRNA inhibits mRNA precursor splicing. J. Biol. Chem. 269:31962-31968.
29. Loeb, L. A., J. M. Essigmann, F. Kazazi, J. Zhang, K. D. Rose, and J. I. Mullins. 1999. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc. Natl. Acad. Sci. USA 96:1492-1497.
30. Loeb, L. A., and J. I. Mullins. 2000. Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res. Hum. Retrovir. 16:1-3.
31. Mateu, M. G. 1995. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res. 38:1-24.
32. Mateu, M. G., J. Hernández, M. A. Martinez, D. Feigelstock, S. Lea, J. J. Pérez, E. Giralt, D. Stuart, E. L. Palma, and E. Domingo. 1994. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J. Virol. 68:1407-1417.
33. Mateu, M. G., M. A. Martinez, L. Capucci, D. Andreu, E. Giralt, F. Sobrino, E. Brocchi, and E. Domingo. 1990. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J. Gen. Virol. 71:629-637.
34. Núñez, J. I., E. Baranowski, N. Molina, C. M. Ruiz-Jarabo, C. Sanchez, E. Domingo, and F. Sobrino. 2001. A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J. Virol. 75:3977-3983.
35. Pariente, N., S. Sierra, P. R. Lowenstein, and E. Domingo. 2001. Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. J. Virol. 75:9723-9730.
36. Parker, W. B., and Y. C. Cheng. 1990. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther. 48:381-395.
37. Pathak, V. K., and H. M. Temin. 1992. 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J. Virol. 66:3093-3100.
38. Pfister, T., and E. Wimmer. 1999. Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J. Biol. Chem. 274:6992-7001.
39. Pincus, S. E., D. C. Diamond, E. A. Emini, and E. Wimmer. 1986. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J. Virol. 57:638-646.
40. Pincus, S. E., and E. Wimmer. 1986. Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity. J. Virol. 60:793-796.
41. Pogolotti, A. L., Jr., and D. V. Santi. 1982. High-pressure liquid chromatography - ultraviolet analysis of intracellular nucleotides. Anal. Biochem. 126: 335-345.
42. Pringle, C. R. 1970. Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate. J. Virol. 5:559-567.
43. Quer, J., C. L. Hershey, E. Domingo, J. J. Holland, and I. S. Novella. 2001. Contingent neutrality in competing viral populations. J. Virol. 75:7315-7320.
44. Ruiz-Jarabo, C. M. 2002. Coevolución de antigenicidad y tropismo celular del virus de la fiebre aftosa y descripción de memoria genética en cuasiespecies víricas. Ph. D. thesis. Universidad Autónoma de Madrid, Madrid, Spain.
45. Ruiz-Jarabo, C. M., A. Arias, C. Molina-Paris, C. Briones, E. Baranowski, C. Escarmis, and E. Domingo. 2002. Duration and fitness dependence of quasispecies memory. J. Mol. Biol. 315:285-296.
46. Ruiz-Jarabo, C. M., C. Ly, E. Domingo, and J. C. de la Torre. 2003. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308:37-47.
47. Sa-Carvalho, D., E. Rieder, B. Baxt, R. Rodarte, A. Tanuri, and P. W. Mason. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71:5115-5123.
48. Saunders, K., and A. M. King. 1982. Guanidine-resistant mutants of aphthovirus induce the synthesis of an altered nonstructural polypeptide, P34. J. Virol. 42:389-394.
49. Saunders, K., A. M. King, D. McCahon, J. W. Newman, W. R. Slade, and S. Forss. 1985. Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants. J. Virol. 56:921-929.
50. Severson, W. E., C. S. Schmaljohn, A. Javadian, and C. B. Jonsson. 2003. Ribavirin causes error catastrophe during Hantaan virus replication. J. Virol. 77:481-488.
51. Sierra, S. 2001. Caracterización de la respuesta del virus de la fiebre aftosa a mutagénesis química. Ph.D. thesis. Universidad Autónoma de Madrid, Madrid, Spain.
52. Sierra, S., M. Davila, P. R. Lowenstein, and E. Domingo. 2000. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J. Virol. 74:8316-8323.
53. Sobrino, F., M. Davila, J. Ortin, and E. Domingo. 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128:310-318.
54. Toja, M., C. Escarmis, and E. Domingo. 1999. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Virus Res. 64:161-171.
55. Traut, T. W. 1994. Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 140:1-22.
56. Wilke, C. O. 2001. Adaptive evolution on neutral networks. Bull. Math Biol. 63:715-730.
57. Wittmann, H. G., and B. Wittmann-Liebold. 1966. Protein chemical studies of two RNA viruses and their mutants. Cold Spring Harb. Symp. Quant. Biol. 31:163-172.
58. Wu, X. P., and B. J. Dolnick. 1993. 5-Fluorouracil alters dihydrofolate reductase pre-mRNA splicing as determined by quantitative polymerase chain reaction. Mol. Pharmacol. 44:22-29.
59. Yu, H., R. Eritja, L. B. Bloom, and M. F. Goodman. 1993. Ionization of bromouracil and fluorouracil stimulates base mispairing frequencies with guanine. J. Biol. Chem. 268:15935-15943.
60. Zibert, A., G. Maass, K. Strebel, M. M. Falk, and E. Beck. 1990. Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J. Virol. 64:2467-2473.